Studies on CRC have shown that MDSCs impair T-cell activation through O2- production and iNOS activity (70, 71), which can be reversed by MDSC depletion or the use of iNOS and O2- inhibitors (72). The gene discussed is NOS2; the disease is colorectal carcinoma.